(Chest. 1999;115:1006-1011.)
© 1999
American College of Chest Physicians
Pulmonary Function Improves After Expandable Metal Stent Placement for Benign Airway Obstruction*
Mark D. Eisner, MD;
Roy L. Gordon, MD;
W. Richard Webb, MD;
Warren M. Gold, MD;
Sameer E. Hilal, BA;
Keith Edinburgh, MD and
Jeffrey A. Golden, MD
*
From the Division of Pulmonary and Critical Care Medicine, Department of
Medicine (Drs. Eisner, Gold, and Golden), the Cardiovascular Research
Institute (Drs. Eisner, Gold, and Mr. Hilal), the Section of Interventional
Radiology (Dr. Gordon), and the Department of Radiology (Drs. Webb and
Edinburgh), University of California, San Francisco, CA. Supported by National
Research Service Award T32 HL07185 (Dr. Eisner).
 |
Abstract
|
|---|
Study objective: To determine whether expandable metal
stent placement for benign airway lesions improves pulmonary
function.
Design: Case series.
Setting: University medical center.
Patients: Nine patients who underwent balloon-mediated
expandable metal stent deployment for airway obstruction due to benign
etiologies.
Results: All nine patients had expandable
stents deployed for benign airway lesions using fiberoptic bronchoscopy
and fluoroscopic guidance. Pulmonary function improved after stent
placement. The mean FVC increased by 388 mL (95% confidence interval
[CI], 30 to 740 mL), the mean peak expiratory flow (PEF) increased by
1,288 mL (95% CI, 730 to 1,840 mL), the mean FEV1
increased by 550 mL (95% CI, 240 to 860 mL), and the mean forced
expiratory flow between 25% and 50% of vital capacity
(FEF2575%) increased by 600 mL (95% CI, 110 to 1,090
mL). Corresponding relative measurements included increases in FVC
(12%), PEF (95%), FEV1 (38%), and
FEF2575% (87%). The complete characterization of a
benign airway obstruction generally required a multimodal
approach.
Conclusions: Expandable metal stent
placement appears to be an effective therapy for benign airway
obstruction.
Key Words: airway obstruction, surgery bronchial diseases, therapy bronchoscopy forced expiratory volume stents
 |
Introduction
|
|---|
Central
airway obstruction can result in dyspnea, cough, and impaired clearance
of respiratory secretions. A variety of benign etiologies can underly
airway obstruction, including tracheomalacia, tracheal stricture,
inflammatory diseases such as Wegener's granulomatosis and relapsing
polychondritis, and anastomotic stricture following lung
transplantation.1
In benign airway lesions, silicone
stents have been used successfully to relieve
obstruction.2
,3
,4
,5
,6
,7
More recently, expandable metal stents
have been deployed in patients with tracheobronchial
obstruction.8
,9
,10
,11
,12
,13
,14
,15
,16
,17
,18
,19
,20
,21
,22
,23
,24
,25
,26
Expandable stents, such as Gianturco
(Cook Cardiology Inc; Bloomington, IN), Palmaz (Johnson and Johnson;
Warren, NJ), and Wallstents (Pfizer; New York, NY), have several
advantages over silicone stents. Expandable stents can be placed by
fiberoptic (vs rigid) bronchoscopy using fluoroscopic
guidance.22
,23
,24
,25
Metal stents become epithelialized,
potentially improving mucociliary clearance.26
In
addition, these stents can be placed more distally in the
tracheobronchial tree using fiberoptic bronchoscopy, thus avoiding the
occlusion of main branch airways. Compared to silicone stents, metal
stents have a larger internal-to-external diameter ratio and are less
likely to migrate.22
,23
,24
,25
,26
The goal of stent placement is to relieve airflow obstruction. The
physiologic impact of silicone stents has been well characterized, with
improvements in FVC, FEV1, and forced expiratory
flow between 25% and 50% of vital capacity
(FEF2575%).27
,28
,29
Likewise,
pulmonary function testing after expandable metal stent placement for
endobronchial carcinoma has revealed improved expiratory
airflow.22
,25
,30
However, the effect of expandable metal
stent deployment on pulmonary function in benign airway obstruction is
less certain. Two studies23
,24
reported an improvement of
FEV1 following expandable stent placement for
benign disease. A further characterization of the postprocedure
pulmonary function was not provided. In this report, we analyze the
impact of expandable metal stent placement on pulmonary function in a
retrospective case series of patients with benign airway lesions.
 |
Materials and Methods
|
|---|
We deployed expandable metal stents in nine patients with
benign tracheal or bronchial stenosis. All of the patients were
symptomatic and had moderate to severe dyspnea. The patients underwent
physiologic, radiologic, and bronchoscopic evaluation before and after
stent placement. Eight patients had spirometry performed (Collins
Cybermedic; Braintree, MA) using a standard protocol conforming to the
guidelines of the American Thoracic Society.31
The FVC,
peak expiratory flow (PEF), FEV1, and
FEF2575% were determined. In addition, the
flow-volume loop contours were studied. Patient 9 had a tracheostomy
and could not undergo spirometry. All of the patients underwent
thoracic CT scanning. Dynamic inspiratory and expiratory images were
obtained to further characterize the location and degree of the airway
obstruction. Every patient underwent fiberoptic bronchoscopy to
directly visualize the airway stenosis. Informed consent was obtained
prior to all procedures.
To minimize discomfort, stent placement was performed under general
anesthesia in all patients. After endotracheal intubation, fiberoptic
bronchoscopy was performed to precisely localize the site of
obstruction. The bronchoscopic visualization of the endobronchial
obstruction was correlated with preoperative thoracic CT scan images
and real-time fluoroscopic imaging. Using CT, fluoroscopy, and
bronchoscopy data, the length and diameter of the lesion was
determined. A guidewire was passed down the bronchoscope and across the
airway lesion. The bronchoscope was then removed, leaving the wire in
position. The stent was then placed over the wire using standard
coaxial techniques. Fluoroscopy was used first to position the stent
and then to facilitate the balloon dilatation of the stent. Using
balloon inflation, the stents were dilated to restore the normal airway
diameter. The bronchoscope was reinserted, and the stent position was
confirmed by direct visual inspection. If necessary, fine-tuning
of the stent position was carried out under fluoroscopic and
bronchoscopic guidance. Maneuvers such as further dilatation,
additional stent placement, and stent manipulation were then performed.
Our goal was to maintain a normal airway diameter without occluding the
side branches with the stent. The goal was eventual epithelialization
of stent struts. Periprocedure antiobiotics or steroids were not
routinely utilized.
To compare the pulmonary function before and after stent placement, a
2-tailed paired t test was used and 95% confidence
intervals (CIs) were constructed.
 |
Results
|
|---|
The mean age (± SD) was 53.7 ± 10.2 years old (range,
34 to 66 years old; Table 1
). There were five men and four women. Five patients had anastomotic
strictures after lung transplantation. In addition, patient 5 had an
extrinsic compression of his left mainstem bronchus by enlarged
thoracic lymph nodes infiltrated with amyloid. Inflammatory airway
disease was caused by Wegener's granulomatosis in one patient, by
relapsing polychondritis in another patient, and by idiopathic
tracheobronchial stenosis in a third patient. Patient 4 had severe
emphysema, with dynamic expiratory collapse of the intrathoracic
trachea demonstrated by both CT scanning and bronchoscopy.
Figure 1
demonstrates improved spirometry after expandable metal stent
placement. The mean FVC increased by 388 mL (95% CI, 30 to 740 mL),
the mean PEF increased by 1,288 mL (95% CI, 730 to 1,840 mL), the mean
FEV1 increased by 550 mL (95% CI, 240 to 860
mL), and the mean FEF2575% increased by 600 mL
(95% CI, 110 to 1,090 mL). The corresponding relative measurements
included increases in FVC (12%), PEF (95%),
FEV1 (38%), and
FEF2575% (87%). In addition, the
FEV1/FVC ratio improved by 130 mL (95% CI, 0 to
260 mL), a 28% improvement.

View larger version (24K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 1. Pulmonary function before and after expandable
metal stent placement. The bar graph depicts the average of each
pulmonary function parameter before and after stent deployment.
|
|
Flow-volume loop contours also improved after stent placement. In
Figure 2
, the preprocedure flow-volume loop (patient 5) demonstrated markedly
diminished expiratory flows with a plateau appearance. After stent
placement, the flow-volume loop reveals increased flows and a
near-normalization of the contour. In all cases, follow-up bronchoscopy
confirmed an improvement in airway diameter immediately following stent
placement.

View larger version (8K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 2. The flow-volume loop before and after expandable
metal stent placement. The left panel depicts the preprocedure
flow-volume loop (patient 5) that demonstrates markedly diminished
expiratory flows and a plateau appearance. After stent placement, the
flow-volume loop (right panel) revealed increased flows and a more
normal-appearing contour.
|
|
In most cases, a multimodal evaluation was necessary to fully
characterize the patient's suitability for stent placement. Patient 6,
for example, had undergone left single-lung transplantation for severe
emphysema. He had a preprocedure flow-volume loop demonstrating
decreased expiratory flows at mid-lung volumes and a reduced vital
capacity (Fig 3
). Given the patient's extremely poor native lung function, we expected
the right mainstem bronchus to function as the main conduit for air
flow. As a result, the obstruction of the right mainstem bronchus
anastomosis would produce an expiratory plateau typically seen with
supracarinal intrathoracic airway obstruction. There is, however, no
clear plateau to suggest such an obstruction. However, dynamic CT scan
(Fig 4
) and fiberoptic bronchoscopy both confirmed an airway obstruction at
the right mainstem bronchial anastomosis. The CT scan demonstrated a
long stenotic segment from the anastomosis into the bronchus
intermedius. With expiration, the bronchus intermedius completely
collapsed, while the proximal right mainstem bronchus narrowed but
remained patent. Thus, the right upper lobe bronchus was able to
ventilate throughout the respiratory cycle, explaining the absence of a
plateau on the flow-volume loop. After stent placement, dynamic CT
scanning demonstrated that the bronchus intermedius remained patent
throughout the respiratory cycle (Fig 4
).

View larger version (12K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 3. The flow-volume loop before and after stent
placement in patient 6. Left: the preprocedure
flow-volume loop that demonstrates diminished expiratory flows at all
lung volumes is shown. No plateau was apparent in the expiratory limb.
Right: increased expiratory flows after expandable metal
stent placement is shown.
|
|

View larger version (67K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 4. Dynamic thoracic CT scanning before and after
expandable metal stent placement. Top, A: the expiratory
thoracic CT image demonstrates a near-total collapse of the bronchus
intermedius. Interestingly, the herniation of the right lung though a
postoperative thoracic wall defect can be seen. Middle,
B: inspiratory thoracic CT image after stent placement
demonstrating a patent bronchus intermedius. Bottom, C:
expiratory CT image after stent placement demonstrating the patency of
the bronchus intermedius throughout the respiratory cycle.
|
|
After the procedure, one patient developed an acute bronchospasm that
responded promptly to nebulized ß-agonist therapy. There were no
instances of postprocedure hemorrhage, pneumothorax, intubation, or
other acute complications. To monitor the clinical adequacy of stent
placement, we followed all of the patients longitudinally. The median
follow-up duration was 23 months (25th to 75th interquartile; range, 20
to 29 months). In all patients, a follow-up bronchoscopy revealed
patent stents with no migration. In eight patients, we observed
epithelialization of the stent struts with no granulation tissue or
overgrowth. In patient 2, we observed endobronchial granulation tissue
similar to what was observed prior to placement of the stent.
Repeat stent placement was required in three patients. For patient 3,
who had relapsing polychondritis, the placement of a tracheal stent did
not relieve the airway obstruction. Excellent results were achieved
after bilateral mainstem bronchial stenting during a second procedure.
Patient 5 had amyloidosis, with progressive thoracic lymphadenopathy
compressing the left mainstem bronchus. As a result, he required a
subsequent left mainstem bronchial stent placement for further
extrinsic narrowing. Patient 2 experienced a progression of her
underlying inflammatory trachoebronchial process, necessitating a
repeat left mainstem bronchial stent placement.
 |
Discussion
|
|---|
In our series of patients with central airway obstruction from
benign lesions, pulmonary function substantially improved after
expandable metal stent placement. Dynamic thoracic CT scanning and
fiberoptic bronchoscopy confirmed an improved airway diameter in all
cases. Our study extends the physiologic observations made previously
concerning expandable metal stent placement for malignant endobronchial
lesions.22
,25
,30
Silicone stents, such as the Dumon stent (Bryan Corp; Woburn,
MA), have long been used to relieve malignant and benign airway
obstructions.1
,2
,3
,4
,5
,6
,7
Several reports have demonstrated a
physiologic improvement after the placement of a silicone stent. Gelb
et al27
described 15 patients who underwent silicone stent
deployment for a variety of benign and malignant etiologies. After
stent placement, there were increases in FVC (14%),
FEV1 (47%), and FEV1/FVC
(32%). A similar review28
of 24 patients after silicone
stent deployment found increases in FVC (9%), PEF (40%),
FEV1 (32%), and
FEF2575% (43%). Other
reports29
,30
have confirmed that respiratory physiology
improves after silicone stenting.
Expandable metal stents improve pulmonary physiology in patients with
malignant airway lesions. Wilson and colleagues22
reported
a series of 56 patients with malignant airway obstruction (47 of whom
had bronchogenic carcinoma) who underwent Gianturco stent placement.
Improvements were noted in FVC (10%), FEV1
(22%), and PEF (18%).
The impact of expandable metal stents on pulmonary function in patients
with benign airway lesions has not been well established. Rousseau and
colleagues24
placed 74 stents for mostly benign
indications and reported the FEV1 for a subset of
16 patients. The FEV1 increased by 38% in 6
patients who received Wallstent prostheses, but there was no
improvement in 10 patients who received Gianturco stents. In a
study25
of 14 patients with anastomotic strictures after
lung transplantation, investigators found a substantial increase in
FEV1 (117%) after expandable metal stent
placement. In both studies, other spirometric measurements were not
reported. Our study extends these observations, demonstrating an
improvement in all four standard spirometric measurements following the
placement of expandable metal stents for benign conditions.
Furthermore, we observed hyperplastic overgrowtha potential problem
with metal stentsin only one patient.
Since stenting provides an effective treatment for central airway
obstruction, the diagnosis of airway lesions becomes important.
Traditionally, the flow-volume loop contour has been pivotal in the
evaluation of patients with suspected central airway
obstruction.27
,32
,33
The detection of a flow-limiting
plateau in either limb of the flow-volume loop suggests an airway
obstruction above the carina. A central airway obstruction, however,
can sometimes be difficult to detect. Obstruction at multiple sites can
produce atypical flow-volume loops, making interpretation
difficult.32
,34
More commonly, patients with COPD may not
manifest typical flow-volume plateaus despite the presence of severe
central airway obstruction.34
,35
,36
,37
These patients may be
incapable of generating sufficient flows to manifest a flow-limiting
plateau, so the expiratory flow-volume limb will manifest decreased
flows at all lung volumes and marked curvilinearity indistinguishable
from severe COPD.35
,36
,37
In such patients, other diagnostic
testing may be required to detect airway obstruction.
In single-lung transplantation patients, the spirometric detection of
an anastomotic bronchial obstruction can also be difficult to achieve.
If native lung function is sufficient, it can contribute to the
flow-volume loop, and no flow-limiting expiratory plateau occurs. If
native lung function is severely impaired, the contralateral mainstem
bronchus might function as a single conduit in series with the
supracarinal airway. In this instance, an anastomotic obstruction can
result in an expiratory plateau. In patient 6, however, the flow-volume
loop had no expiratory plateau despite significant anastomotic
obstruction and extremely poor native lung function. In this case,
dynamic CT scanning demonstrated a long area of airway stenosis from
the anastomosis into the bronchus intermedius. With expiration, the
distal stenotic segment (in the bronchus intermedius) collapsed, but
the proximal right mainstem bronchus remained patent enough to allow
right upper lobe ventilation. As a result, no expiratory plateau
occurred. Therefore, the detection of anastomotic strictures in
single-lung transplant patients often requires a multimodal approach,
including spirometry, thoracic CT scanning, and bronchoscopy.
There are several limitations to our study. Our sample was a small,
highly selected group of patients. As a result, the efficacy of
expandable metal stent placement in other benign airway disorders
requires further study. Also, repeat stent placement was commonly
necessary to maintain a clinical benefit, necessitating a careful
clinical follow-up. Finally, this study focuses on the short-term
physiologic benefits of expandable metallic stent placement. The impact
on longer term clinical outcomes such as quality of life, health care
utilization, and mortality remains to be characterized.
We have demonstrated that expandable metal stent placement using
fiberoptic bronchoscopy and fluoroscopic control improves pulmonary
function in patients with benign airway lesions. A multimodal approach
is often required to adequately evaluate a benign airway obstruction.
 |
Footnotes
|
|---|
Correspondence to: Mark D. Eisner MD, Division of Pulmonary and
Critical Care Medicine, University of California, San Francisco, 350
Parnassus Ave, Suite 609, San Francisco, CA 94143-0924; e-mail:
eisner@itsa.ucsf.edu
Abbreviations: CI = confidence
interval; PEF = peak expiratory flow;
FEF2575% = forced expiratory flow between 25% and
75% of vital capacity
Received for publication June 25, 1998.
Accepted for publication November 2, 1998.
 |
References
|
|---|
-
Colt, HG, Dumon, JF (1995) Airway stents: present and future. Clin Chest Med 16,465-478[ISI][Medline]
-
Cooper, JD, Pearson, FG, Patterson, GA, et al (1989) Use of silicone stents in the management of airway problems. Ann Thorac Surg 47,371-378[Abstract]
-
Sonnett, JR, Keenan, RJ, Ferson, PF, et al (1995) Endobronchial management of benign, malignant, and lung transplantation airway stenoses. Ann Thorac Surg 59,1417-1422[Abstract/Free Full Text]
-
Martinez-Ballarin, JI, Diaz-Jimenez, JP, Castro, MJ, et al (1996) Silicone stents in the management of benign tracheobronchial stenoses: tolerence and early results in 63 patients. Chest 109,626-629[Abstract/Free Full Text]
-
Gaer, ARJ, Tsang, V, Khaghani, A, et al (1992) Use of endobronchial silicone stents for relief of tracheobronchial obstruction. Ann Thorac Surg 54,512-516[Abstract]
-
Bollinger, CT, Probst, R, Tschopp, K, et al (1993) Silicone stents in the management of inoperable tracheobronchial stenoses: indications and limitations. Chest 104,1653-1659[Abstract/Free Full Text]
-
Colt, HG, Janssen, JP, Dumon, JF, et al (1992) Endoscopic management of bronchial stenosis after double lung transplantation. Chest 102,10-16[Abstract/Free Full Text]
-
Carrasco, CH, Nesbitt, JC, Charnsangavej, C, et al (1994) Management of tracheal and bronchial stenoses with the Gianturco stent. Ann Thorac Surg 59,1012-1017
-
Egan, AM, Dennis, C, Flower, CDR (1994) Expandable metal stents for tracheobronchial obstruction. Clin Radiol 49,162-165[CrossRef][ISI][Medline]
-
Sawada, S, Fujiwara, Y, Furui, S (1994) Treatment of tuberculous bronchial stenosis with expandable metallic stents. Acta Radiol 34,263-265
-
George, PJM, Irving, JD, Khaghani, A, et al (1992) Role of the Gianturco expandable metal stent in the management of tracheobronchial obstruction. Cardiovasc Intervent Radiol 15,375-381[ISI][Medline]
-
Nasherf, SAM, Dromer, C, Velly, JF, et al (1992) Expanding wire stents in benign tracheobroncial disease: indications and complications. Ann Thorac Surg 54,937-940[Abstract]
-
Nomori, H, Kobayashi, R, Kodera, K, et al (1993) Indications for an expandable metallic stent for tracheobronchial stenosis. Ann Thorac Surg 56,1324-1328[Abstract]
-
De Souza, AC, Keal, R, Hudsan, NM, et al (1994) Use of expandable wire stents for malignant airway obstruction. Ann Thorac Surg 57,1573-1578[Abstract]
-
Brichon, PY, Blanc-Jouvan, F, Rousseau, H (1992) Endovascular stents for bronchial stenosis after lung transplantation. Transplant Proc 24,2656-2659[ISI][Medline]
-
Carre, P, Rousseau, H, Lombart, L (1994) Balloon dilatation and self-expanding metal Wallstent insertion: for management of bronchostenosis following lung transplantation. Chest 105,343-348[Abstract/Free Full Text]
-
Zannini, P, Melloni, G, Chiesa, G (1994) Self-expanding stents in the treatment of tracheobronchial obstruction. Chest 106,86-90[Abstract/Free Full Text]
-
Shah, R, Sabanathan, S, Mearns, AJ (1995) Self-expanding tracheobronchial stents in the management of major airway problems. J Cardiovasc Surg 36,343-348[Medline]
-
Filler, RM, Forte, V, Fraga, JC (1995) The use of expandable metallic airway stents for tracheobronchial obstruction in children. J Pediatr Surg 30,1050-1056[CrossRef][ISI][Medline]
-
Tayama, K, Takamori, S, mitsuoka, M, et al (1997) Experience of expandable metallic stents for central airway obstruction. Jpn J Clin Oncol 27,401-405[Abstract/Free Full Text]
-
Slonim, SM, Razavi, M, Kee, S, et al (1998) Transbronchial Palmaz stent placement for tracheo-bronchial stenosis. J Vasc Interv Radiol 9,153-160[ISI][Medline]
-
Wilson, GE, Walshaw, MJ, Hind, CRK (1996) Treatment of large airway obstruction in lung cancer using expandable metal stents inserted under direct vision via the fiberoptic bronchoscope. Thorax 51,248-252[Abstract]
-
Higgins, R, McNeil, K, Dennis, C, et al (1994) Airway stenoses after lung transplantation: management with expanding metal stents. J Heart Lung Transplant 13,774-778[ISI][Medline]
-
Rousseau, J, Dahan, M, Lauque, D, et al (1993) Self-expandable protheses in the tracheobronchial tree. Radiology 188,199-203[Abstract/Free Full Text]
-
Sawada, S, Tanigawa, N, Kobayashi, M, et al (1993) Malignant tracheobronchial obstructive lesions: treatment with Gianturco expandable metallic stents. Radiology 188,205-208[Abstract/Free Full Text]
-
Tojo, T, Iioka, S, Kitamura, S (1996) Management of malignant tracheobronchial stenosis with metal stents and Dumon stents. Ann Thorac Surg 61,1074-1078[Abstract/Free Full Text]
-
Gelb, AF, Zamel, N, Colchen, A, et al (1992) Physiologic studies of tracheobronchial stents in airway obstruction. Am Rev Respir Dis 146,1088-1090[ISI][Medline]
-
Vergnon, JM, Costes, F, Bayon, MC, et al (1995) Efficacy of tracheal and bronchial stent placement on respiratory functional tests. Chest 107,741-746[Abstract/Free Full Text]
-
Abdullah, V, Yim, AP, Wormald, PJ, et al (1998) Dumon silicone stents in obstructive tracheobronchial lesions: the Hong Kong experience. Otolaryngol Head Neck Surg 118,256-260[CrossRef][ISI][Medline]
-
Hauck, RW, Lembeck, RM, Emslander, HP, et al (1997) Implantation of Accuflex and Strecker stents in malignant bronchial stenoses by flexible bronchoscopy. Chest 112,134-144[Abstract/Free Full Text]
-
. American Thoracic Society. (1995) Standardization of spirometry: 1994 update. Am J Respir Crit Care Med 152,1107-1136[ISI][Medline]
-
Miller RD, Hyatt RE. Evaluation of obstructing lesions of the trachea and larynx by flow-volume loops. Am Rev Respir Dis 1973:475481
-
Miller, RD, Hyatt, RE (1969) Obstructing lesions of the larynx and trachea: clinical and physiologic characteristics. Mayo Clin Proc 44,145-161[ISI][Medline]
-
Gamsu, G, Borson, DB, Webb, WR, et al (1980) Structure and function in tracheal stenosis. Am Rev Respir Dis 121,519-531[ISI][Medline]
-
Gelb, AF, Tashkin, DP, Epstein, JD, et al (1987) Nd-YAG laser surgery for severe tracheal stenosis physiologically and clinically masked by severe diffuse obstructive pulmonary disease. Chest 91,166-170[Abstract/Free Full Text]
-
Mohsenifar, Z, Jasper, AC, Koerner, SK (1988) Physiologic assessment of lung function in patients undergoing laser photoresection of tracheobronchial tumors. Chest 93,65-69[Abstract/Free Full Text]
-
Gelb, AF, Tashkin, DP, Epstein, JD, et al (1988) Physiologic characteristics of malignant unilateral mainstem bronchial obstruction. Am Rev Respir Dis 138,1382-1385[ISI][Medline]
This article has been cited by other articles:

|
 |

|
 |
 
A. M. Rampey, G. A. Silvestri, and M. B. Gillespie
Combined Endoscopic and Open Approach to the Removal of Expandable Metallic Tracheal Stents
Arch Otolaryngol Head Neck Surg,
January 1, 2007;
133(1):
37 - 41.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. P. Madden, T.-K. Loke, and A. C. Sheth
Do expandable metallic airway stents have a role in the management of patients with benign tracheobronchial disease?
Ann. Thorac. Surg.,
July 1, 2006;
82(1):
274 - 278.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. H. Thornton, R. L. Gordon, R. K. Kerlan, J. M. LaBerge, M. W. Wilson, K. A. Wolanske, M. B. Gotway, G. S. Hastings, and J. A. Golden
Outcomes of tracheobronchial stent placement for benign disease.
Radiology,
July 1, 2006;
240(1):
273 - 282.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Carden, P. M. Boiselle, D. A. Waltz, and A. Ernst
Tracheomalacia and Tracheobronchomalacia in Children and Adults: An In-depth Review
Chest,
March 1, 2005;
127(3):
984 - 1005.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Ernst, D. Feller-Kopman, H. D. Becker, and A. C. Mehta
Central Airway Obstruction
Am. J. Respir. Crit. Care Med.,
June 15, 2004;
169(12):
1278 - 1297.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. W. Hauck, M. Barbur, R. Lembeck, F. Peltz, and M. Werner
Cellular Composition of Stent-Penetrating Tissue
Chest,
November 1, 2002;
122(5):
1615 - 1621.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. P. Madden, S. Datta, and N. Charokopos
Experience with ultraflex expandable metallic stents in the management of endobronchial pathology
Ann. Thorac. Surg.,
March 1, 2002;
73(3):
938 - 944.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kim, M. B. Gotway, W. R. Webb, R. L. Gordon, and J. A. Golden
Tracheal Compression by the Stomach Following Gastric Pull-Up : Diagnosis With CT and Treatment With Expandable Metallic Stent Placement
Chest,
March 1, 2002;
121(3):
998 - 1001.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Yanagihara, K. Matsuoka, N. Hanaoka, K. Toda, and K. Muro
Inflammatory endobronchial stenosis
Ann. Thorac. Surg.,
February 1, 2001;
71(2):
698 - 699.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Miyazawa, Y. Miyazu, Y. Iwamoto, A. Ishida, K. Kanoh, H. Sumiyoshi, M. Doi, and N. Kurimoto
Stenting at the Flow-limiting Segment in Tracheobronchial Stenosis due to Lung Cancer
Am. J. Respir. Crit. Care Med.,
May 15, 2004;
169(10):
1096 - 1102.
[Abstract]
[Full Text]
[PDF]
|
 |
|